Related Experiment Video
Updated: Jun 25, 2026
07:20
Studies on the Anti-Inflammatory Effect of Xiaoyao Pills in The Treatment of Postmenopausal Osteoporosis in Mice
Published on: August 23, 2024
Emerging drugs for postmenopausal osteoporosis.
1New Mexico Clinical Research & Osteoporosis Center, 300 Oak Street NE, Albuquerque, New Mexico 87106, USA. LEWIECKI@aol.com
Expert Opinion on Emerging Drugs
|March 3, 2009
Summary
Emerging treatments for postmenopausal osteoporosis (PMO) show promise in reducing fracture risk. New drugs and delivery systems aim to improve efficacy and patient adherence, addressing the significant burden of osteoporotic fractures.
Area of Science:
- Endocrinology
- Pharmacology
- Bone Biology
Background:
- Postmenopausal osteoporosis (PMO) is a prevalent skeletal disease leading to debilitating fractures.
- Current treatments face challenges in prescription rates, adherence, and managing adverse effects.
- Understanding PMO pathophysiology drives the development of novel therapeutic strategies.
Purpose of the Study:
- To review the efficacy and safety of emerging drugs for postmenopausal osteoporosis.
- To explore new therapeutic agents, delivery systems, and combination therapies.
- To assess the potential of these advancements in mitigating the impact of osteoporotic fractures.
Main Methods:
- Review of clinical trial data and scientific literature on emerging PMO therapies.
- Analysis of novel mechanisms of action, including denosumab, odanacatib, and sclerostin inhibitors.
- Evaluation of new estrogen agonists/antagonists and improved delivery systems for existing drugs.
Main Results:
- Emerging agents with novel mechanisms (e.g., denosumab) demonstrate significant potential.
- New estrogen receptor modulators and improved drug delivery systems offer alternative treatment options.
- Combination therapies are being investigated to enhance treatment outcomes.
Conclusions:
- New therapeutic agents and strategies hold promise for improving postmenopausal osteoporosis management.
- Advancements in drug development and delivery may reduce the personal and economic burden of fractures.
- Further research is needed to optimize the use of these emerging treatments.
Related Concept Videos
01:28Menopause
Menopause, a natural biological process marking the end of a woman's fertility, typically occurs between the fifth and sixth decade of life. This phase is characterized by the exhaustion of the ovarian follicle pool, leading to less responsive ovaries despite the high levels of Follicle Stimulating Hormone (FSH) and Luteinizing Hormone (LH). The consequential decrease in estrogen production results in symptoms like hot flashes, heavy sweating, headaches, hair loss, muscle pains, vaginal...
01:29Bone Disorders
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
01:30Hormonal Control of the Ovarian Cycle
The ovarian cycle is meticulously regulated by the hypothalamic-pituitary-gonadal axis. This cycle orchestrates the release of a mature oocyte, essential for reproduction.
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle. At puberty, GnRH secretion increases in both frequency and...
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle. At puberty, GnRH secretion increases in both frequency and...
01:31Essential Minerals for Bone Health
The minerals contained in all of the food we consume are essential for our organ systems. However, certain essential minerals, such as calcium, phosphorus, magnesium, manganese, and fluoride, largely affect bone health.
Calcium and Phosphorus
Calcium is a critical component of bones, especially in the form of calcium phosphate and calcium carbonate. Since the body cannot make calcium, it must be obtained from the diet. However, calcium cannot be absorbed from the small intestine without...
Calcium and Phosphorus
Calcium is a critical component of bones, especially in the form of calcium phosphate and calcium carbonate. Since the body cannot make calcium, it must be obtained from the diet. However, calcium cannot be absorbed from the small intestine without...
01:20Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
01:17Hormones and Bone Tissue
The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...